Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme

Published:2003-06 Issue:3 Volume:5 Page:261-270
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

McMurray J.¹,Östergren J.²,Pfeffer M.³,Swedberg K.⁴,Granger C.⁵,Yusuf S.⁶,Held P.⁷,Michelson E.⁸,Olofsson B.⁷,

Affiliation:

1. Department of Cardiology, Western Infirmary; University of Glasgow; Glasgow G11 6NT Scotland UK

2. Karolinska Hospital; Stockholm Sweden

3. Brigham and Women's Hospital; Boston MA USA

4. Department of Medicine; Sahlgrenska University Hospital/Östra; Goteborg Sweden

5. Duke University Medical Center; Durham NC USA

6. HGM-McMaster Clinic; Hamilton Ont. Canada

7. AstraZeneca, R&D, Moindal; Sweden

8. AstraZeneca LP; Wayne PA USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM): rationale and design. CHARM-Programme Investigators;Swedberg;J Card Fail,1999

2. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective;Vasan;J Am Coll Cardiol,1995

3. Heart failure associated with preserved systolic function: a common and costly clinical entity;Dauterman;Am Heart J,1998

4. Changes in notions about heart failure;Petrie;Lancet,2001

5. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial;Lancet,1999

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY‐HFpEF trial;ESC Heart Failure;2023-11-20

2. Diagnosis of heart failure with preserved ejection fraction: a systematic narrative review of the evidence;Heart Failure Reviews;2023-10-20

3. Prognostic impact of red blood cell distribution width in chronic heart failure patients with left ventricular dysfunction;Journal of Cardiovascular Medicine;2023-10

4. Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER;European Journal of Heart Failure;2023-09

5. Health status across major subgroups of patients with heart failure and preserved ejection fraction;European Journal of Heart Failure;2023-04-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3